100,000 Signatures Needed for Parliamentary Debate - Save The NHS 100, For Every 1

Spent On Lymphoedema Treatments

Jane Durston, Operations Manager at The British Lymphology Society has surveyed
BLS member views on Lymphoedema Awareness Week 2015 and has created the petition
"Save the NHS 100, for every 1 spent on lymphoedema treatments". As Corporate Mem
bers of BLS, PhysioPod UK Limited have added their names to the petition and wou
ld really appreciate the support of others in adding their name too.
Nottingham, Nottinghamshire, England, December 29, 2014 -- Jane Durston, Operati
ons Manager at The British Lymphology Society has surveyed BLS member views on L
ymphoedema Awareness Week 2015 and has created the petition "Save the NHS 100, fo
r every 1 spent on lymphoedema treatments". As Corporate Members of BLS, PhysioPo
d UK Limited have added their names to the petition and would really appreciate
the support of others in adding their name too.
"The campaign is very important to Jane Durston and the more support behind it,
the better chance there is of succeeding.
You can read more and SIGN the petition here and you can also read more below fr
om Jane Durston:
https://you.38degrees.org.uk/petitions/save-the-nhs-100-for-every-1-spent-on-lym
phoedema-treatments
To: Dame Barbara Hakin, National Director - Commissioning Development, NHS Engla
nd
Save the NHS 100 - for every 1 spent on lymphoedema treatments
Campaign created by The British Lymphology Society Jane Durston
Develop a lymphoedema strategy for England
Why is this important?
Lymphoedema is a long-term condition defined as tissue swelling due to a failure
of lymphatic drainage. It can affect any part of the body. (NCAT 2013) An esti
mated 240,000 men, women and children in the UK have lymphoedema, many of whom r
emain undiagnosed and untreated (LSN 2014). With an ageing population and increa
sing obesity, this figure is set to rise.
Money is currently being wasted treating the symptoms of unmanaged lymphoedema (
NCAT 2013).
For every 1.00 spent on lymphoedema treatments that limit swelling and prevent da
mage and infection, the NHS saves an estimated 100 in reduced hospital admissions
. (NCAT 2013)
National strategies for lymphoedema services have already been established in Wa
les, Northern Ireland and Scotland. (NCAT 2013)
There is no national tariff available for lymphoedema - although the British Lym
phology Society have published a National Lymphoedema Tariff Advisory Document w
hich sets out proposals for achieving this. (BLS 2014).
Once treated and controlled; lymphoedema can be self-managed with the right supp
ort and within a good clinical infrastructure. (NCAT 2013)
There are no minimal educational standards for lymphoedema practitioners, althou

gh the International Lymphoedema Framework project sets out a skills framework.

The British Lymphology Society has also published a document setting out "Popula
tion Needs assessment and professional roles in the care of lymphoedema" (BLS 20
14) and a "Treatment Pathway for Lymphoedema Patients with a Body Mass Index (BM
I) equal or great than 40kg/m2".
The Lymphoedema Support Network (LSN) has also produced an award-winning GP trai
ning module on lymphoedema.
75% of lymphoedema is non-cancer related and 25% is cancer related, therefore it
cuts across specialities. (NCAT 2013).
Cellulitis is an acute spreading inflammation of the skin and subcutaneous tissu
es characterised by pain, warmth, swelling and erythema. (BLS/LSN 2014).
Admissions to hospital with cellulitis, the most common complication of lymphoed
ema, are a significant burden on local health care services. The cost of hospita
l admissions for cellulitis in Derbyshire, Nottinghamshire and Lincolnshire was
approx 4.1m in one year (population of 2.5 million). (NCAT 2013).
The British Lymphology Society has been writing to NHS England at regular interv
als for over a year to try and address these matters - to date they have receive
d no response. Lymphoedema could happen to any one of us and common sense should
guide NHS England policy - conservative treatment and prevention is not only pr
eferable to; but cheaper than, the present state of affairs."
About PhysioPod UK Ltd:
PhysioPod UK Ltd are now in their 8th year of trading. Directed by Sisters, Julie
Soroczyn and Mary Fickling, PhysioPod exclusively supply the UK and Ireland with
internationally patented DEEP OSCILLATION electrostatic massage therapy. Non-inv
asive, non-traumatic, electrostatic impulses are delivered through vinyl gloves
or applicator heads, permeating an 8 cm depth through all tissue layers includin
g skin, sub-coetaneous fat, muscles, blood and lymph vessels, with clinically pr
oven effects in the interstitial spaces of the connective tissue. PhysioPod UK Li
mited are approved NHS Suppliers. http://www.physiopod.co.uk
Contact:
Mary Fickling
PhysioPod UK Limited
Sherbrook Road
Daybrook, Nottingham, NG5 6AS
01159167685
info@physiopod.co.uk
http://www.physiopod.co.uk